The prize was presented as part of the OBN annual awards night on 2 October where other winners included Oxford AHSN partners Intelligent Ultrasound (Emerging Medtech Company) and Isansys (Best New Medtech Development Programme).
The Oxford AHSN sponsored the public-private collaboration prize to reward organisations which are helping to break down traditional boundaries between the NHS, universities, science and business.
The judges said of the Bedford-Cranfield partnership: “The cream of British talent worked together to develop the OsteoVibe, a mobile, automatic, low cost, radiation free and reliable diagnostic tool for osteoporosis/bone fractures in primary care settings.
“At its core, OsteoVibe uses non-invasive bone excitation technology which – unlike other bone diagnostics – poses no additional health risks to patients. The technology has been experimentally validated under laboratory conditions at Cranfield University.
“Once the engineering prototype has been completed, Bedford Hospital NHS Trust will conduct clinical studies.”